Literature DB >> 16091208

Granulomatous disease in common variable immunodeficiency.

Yoshikazu Morimoto1, John M Routes.   

Abstract

Common variable immunodeficiency (CVID) is a primary immunodeficiency of unknown etiology characterized by low levels of immunoglobulin (Ig)G, failure to make specific antibodies in response to infection or immunization, and variable T-cell abnormalities. Multisystemic granulomatous disease is a well-documented complication of CVID, and its presence is associated with significant morbidity and early mortality. Although the lung is the most common organ system affected, granulomas are also found frequently in other organs, including skin, liver, spleen, and the gastrointestinal tract. Autoimmune disorders are common in these patients, and there appears to be an increased propensity to develop lymphoproliferative disorders. Common physical, radiographic, and laboratory abnormalities in patients with CVID and granulomatous disease include splenomegaly, hilar and mediastinal lymphadenopathy with ground glass or nodular opacities in the lung parenchyma, and reduced T-cell numbers and function. The etiology of granulomatous disease in patients with CVID is unknown, and optimal treatment of granulomatous disease in CVID remains to be established. Further studies are needed to elucidate the underlying etiology of granulomatous lymphoproliferative interstitial lung disease and to delineate appropriate treatments for this disease.

Entities:  

Mesh:

Year:  2005        PMID: 16091208     DOI: 10.1007/s11882-005-0008-x

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.919


  38 in total

1.  Cutaneous and hepatic granulomas in a young woman with common variable immunodeficiency.

Authors:  P Cornejo; A Romero; S López; A Guerra; R Gil; L Iglesias
Journal:  Br J Dermatol       Date:  1999-03       Impact factor: 9.302

2.  Course and prognosis of sarcoidosis.

Authors:  M SONES; H L ISRAEL
Journal:  Am J Med       Date:  1960-07       Impact factor: 4.965

3.  Gammadelta T lymphocytosis associated with granulomatous disease in a patient with common variable immunodeficiency.

Authors:  Jean-François Viallard; Coralie Bloch-Michel; Olivier Caubet; Marie Parrens; Jeannette Texier-Maugein; Martine Neau-Cransac; Jean-Luc Taupin; Jean-François Moreau; Jean-Luc Pellegrin
Journal:  Clin Infect Dis       Date:  2002-12-02       Impact factor: 9.079

4.  Granulomatous renal disease in a patient with common variable immunodeficiency.

Authors:  F Fakhouri; C Robino; M Lemaire; D Droz; L H Noël; B Knebelmann; P Lesavre
Journal:  Am J Kidney Dis       Date:  2001-08       Impact factor: 8.860

5.  Constitutive cytokine production by primary effusion (body cavity-based) lymphoma-derived cell lines.

Authors:  H G Drexler; C Meyer; G Gaidano; A Carbone
Journal:  Leukemia       Date:  1999-04       Impact factor: 11.528

6.  Common variable immunodeficiency treated with a recombinant human IgG, tumour necrosis factor-alpha receptor fusion protein.

Authors:  K J Smith; H Skelton
Journal:  Br J Dermatol       Date:  2001-03       Impact factor: 9.302

7.  The simultaneous presentation of sarcoidosis and common variable immune deficiency.

Authors:  R Ameratunga; D M Becroft; W Hunter
Journal:  Pathology       Date:  2000-11       Impact factor: 5.306

8.  Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice.

Authors:  I Screpanti; P Musiani; D Bellavia; M Cappelletti; F B Aiello; M Maroder; L Frati; A Modesti; A Gulino; V Poli
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

9.  Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency.

Authors:  Christopher A Bates; Misoo C Ellison; David A Lynch; Carlyne D Cool; Kevin K Brown; John M Routes
Journal:  J Allergy Clin Immunol       Date:  2004-08       Impact factor: 10.793

Review 10.  Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings.

Authors:  K M Thickett; D S Kumararatne; A K Banerjee; R Dudley; D E Stableforth
Journal:  QJM       Date:  2002-10
View more
  43 in total

1.  International Consensus Document (ICON): Common Variable Immunodeficiency Disorders.

Authors:  Francisco A Bonilla; Isil Barlan; Helen Chapel; Beatriz T Costa-Carvalho; Charlotte Cunningham-Rundles; M Teresa de la Morena; Francisco J Espinosa-Rosales; Lennart Hammarström; Shigeaki Nonoyama; Isabella Quinti; John M Routes; Mimi L K Tang; Klaus Warnatz
Journal:  J Allergy Clin Immunol Pract       Date:  2015-11-07

Review 2.  How I treat common variable immune deficiency.

Authors:  Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2010-03-23       Impact factor: 22.113

Review 3.  Common variable immune deficiency: reviews, continued puzzles, and a new registry.

Authors:  Charlotte Cunningham-Rundles; Adina Kay Knight
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

4.  [Inflammatory reactions of the spleen].

Authors:  T Rüdiger; M Hartmann; H K Müller-Hermelink; A Marx
Journal:  Pathologe       Date:  2008-03       Impact factor: 1.011

5.  Autoimmune Cytopenias and Associated Conditions in CVID: a Report From the USIDNET Registry.

Authors:  Elizabeth J Feuille; Niloofar Anooshiravani; Kathleen E Sullivan; Ramsay L Fuleihan; Charlotte Cunningham-Rundles
Journal:  J Clin Immunol       Date:  2017-10-28       Impact factor: 8.317

Review 6.  New insights into gastrointestinal and hepatic granulomatous disorders.

Authors:  Majid A Almadi; Abdulrahman M Aljebreen; Faisal M Sanai; Victoria Marcus; Ebtissam S Almeghaiseeb; Subrata Ghosh
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-08-05       Impact factor: 46.802

7.  Granulomatous disease: distinguishing primary antibody disease from sarcoidosis.

Authors:  D F Arnold; J Wiggins; C Cunningham-Rundles; S A Misbah; H M Chapel
Journal:  Clin Immunol       Date:  2008-05-16       Impact factor: 3.969

8.  Infliximab for treatment of granulomatous disease in patients with common variable immunodeficiency.

Authors:  Timothy J Franxman; Laura E Howe; James R Baker
Journal:  J Clin Immunol       Date:  2014-07-27       Impact factor: 8.317

Review 9.  Common variable immune deficiency: Dissection of the variable.

Authors:  Charlotte Cunningham-Rundles
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

Review 10.  Immunodeficiencies.

Authors:  M Ballow; L Notarangelo; B Grimbacher; C Cunningham-Rundles; M Stein; M Helbert; B Gathmann; G Kindle; A K Knight; H D Ochs; K Sullivan; J L Franco
Journal:  Clin Exp Immunol       Date:  2009-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.